Evidence of increased oxidative damage in both sporadic and familial amyotrophic lateral sclerosis

Journal of Neurochemistry

Volumn 69, Issue 5, 1997, Pages 2064-2074

  Ferrante, Robert J ^c   Browne, Susan E ^a   Shinobu, Leslie A ^a   Bowling, Allen C ^a   Baik, M Jay ^a   MacGarvey, Usha ^a   Kowall, Neil W ^c   Brown Jr , Robert H ^a   Beal, M Flint ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c NONE

Author keywords

Amyotrophic lateral sclerosis; Free radicals; Neurodegeneration; Oxidative damage; Superoxide dismutase

Indexed keywords

FREE RADICAL;

AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; AUTOSOMAL DOMINANT DISORDER; BRAIN CORTEX; CONTROLLED STUDY; FAMILIAL DISEASE; GENE MUTATION; HUMAN; HUMAN TISSUE; NERVE DEGENERATION; OXIDATIVE STRESS; PRIORITY JOURNAL;

EID: 0030813067     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.1997.69052064.x     Document Type: Article

References (60)

1. Abe K., Pan L.-H., Watanabe M., Kato T., and Itoyama Y. (1995) Induction of nitrotyrosine-like immunoreactivity in the lower motor neuron of amyotrophic lateral sclerosis. Neurosci. Lett. 199, 152-154.
2. Aoki M., Nakamura S., Itoyama T., Abe K., Ogasawara M., Matsubara Y., and Narisawa K. (1993) Mild ALS in Japan associated with novel SOD mutation. Nat Genet. 5, 323-324.
3. Beal M. F., Ferrante R. J., Matthews R. T., Kowall N. W., and Brown R. H. (1996) 3-Nitrotyrosine in ALS. Soc. Neurosci. Abstr. 22, 1943.
4. Beckman J. S., Carson M., Smith C. D., and Koppenol W. H. (1993) ALS, SOD and peroxynitrite. Nature 364, 584.
5. Blaauwgeers H. G. T., Vianney de Jong J. M. B., Verspaget H. W., van den Berg F. M., and Troost D. (1996) Enhanced Superoxide dismutase-2 immunoreactivity of astrocytes and occasional neurons in amyotrophic lateral sclerosis. J. Neurol. Sci. 140, 21-29.
6. Borchelt D. R., Lee M. K., Lunt H. S., Guarnieri M., Xu Z.-S., Wong P. C., Brown R. H. Jr., Price D. L., Sisodia S. S., and Cleveland D.W. (1994) Superoxide dismutase 1 with mutations linked to familial amyotrophic lateral sclerosis possesses significant activity. Proc. Natl. Acad. Sci. USA 91, 8292-8296.
7. Bowling A. C., Schulz J. B., Brown R. H. Jr., and Beal M. F. (1993) Superoxide dismutase activity, oxidative damage, and mitochondrial energy metabolism in familial and sporadic amyotrophic lateral sclerosis. J. Neurochem. 61, 2322-2325.
8. Bowling A. C., Barkowski E. E., McKenna-Yasek D., Sapp P., Horvitz H. R., Beal M. F., and Brown R. H. Jr. (1995) Superoxide dismutase concentration and activity in familial amyotrophic lateral sclerosis. J. Neurochem. 64, 2366-2369.
9. Brown R. H. Jr. (1995) Amyotrophic lateral sclerosis: recent insights from genetics and transgenic mice. Cell 80, 687-692.
10. Castellani R., Smith M. A., Richey P. L., and Perry G. (1996) Glycoxidation and oxidative stress in Parkinson disease and diffuse lewy body disease. Brain Res. 737, 195-200.
11. Chirico S. (1994) High performance liquid chromatography-based thiobarbituric acid tests. Methods Enzymol. 223, 314-318.
12. Chou S. M., Wang H. S., and Komai K. (1996) Colocalization of NOS and SOD1 in neurofilament accumulation within motor neurons of amyotrophic lateral sclerosis: an immunohistochemical study. J. Chem. Neuroanat. 10, 249-258.
13. Cudkowicz M. E., McKenna-Yasek D., Sapp P. E., Chin W., Geller B., Hayden D. L., Schoenfeld D. A., Hosler B. A., Horvitz H. R., and Brown R. H. (1997) Epidemiology of mutations in Superoxide dismutase in amyotrophic lateral sclerosis. Ann. Neurol. 41, 210-221.
14. Deng H.-X., Hentati A., Tainer J. A., Iqbal Z., Cayabyab A., Hung W.-Y., Getzoff E. D., Hu P., Herzfeldt B., Roos R. P., Warner C., Deng G., Soriano E., Smyth C., Parge H. F., Ahmed A., Roses A. D., Hallewell R. A., Pericak-Vance M. A., and Siddique T. (1993) Amyotrophic lateral sclerosis and structural defects in Cu,Zn Superoxide dismutase. Science 261, 1047-1051.
15. Dizdaroglu M. (1991) Chemical determination of free radical-induced damage to DNA. Free Radic. Biol. Med. 10, 225-242.
16. Dugan L. L., Turetsky D. M., Du C., Lin T. T., Lobner D., Almli R., Wheeler M., and Choi D. W. (1996) Carboxy-buckminster-fullerenes: novel antioxidants with neuroprotective efficacy in vitro and in a mouse model of ALS. Soc. Neurosci. Abstr. 22, 2142.
17. Dwyer B. E., Nishimura R. N., and Lu S.-Y. (1995) Differential expression of heme oxygenase-1 in cultured cortical neurons and astrocytes determined by the aid of a new heme oxygenase antibody. Response to oxidative stress. Mol. Brain Res. 30, 37-47.
18. Elshafev A., Lanvon W. G., and Connor J. M. (1994) Identification of a new missense point mutation in exon 4 of the Cu,Zn superoxide dismutase (SOD) gene in a family with amyotrophic lateral sclerosis. Hum. Mol. Genet. 3, 363-364.
19. Ferrante R. J., Kowall N. W., Cipolloni P. B., Storey E., and Beal M. F. (1993) Excitotoxin lesions in primates as a model for Huntington's disease: histopathologic and neurochemical characterization. Exp. Neurol. 119, 46-71.
20. Fukuda K., Panter S. S., Sharp F. R., and Noble L. J. (1995) Induetion of heme oxygenase-1 (HO-1) after traumatic brain injury in the rat. Neurosci. Lett. 199, 127-130.
21. Gurney M. E., Pu H., Chiu A. Y., Dal Canto M. C., Polchow C. Y., Alexander D. D., Caliendo J., Hentati A., Kwon Y. W., Deng H.-X., Chen W., Zhai P., Sufit R. L., and Siddique T. (1994) Motor neuron degeneration in mice that express a human Cu,Zn Superoxide dismutase mutation. Science 264, 1772-1775.
22. Gurney M. E., Cutting F. B., Zhai P., Doble A., Taylor C. P., Andrus P. K., and Hall E. D. (1996) Benefit of vitamin E, riluzole, and gabapentin in a transgenic model of familial amyotrophic lateral sclerosis. Ann. Neurol. 39, 147-157.
23. Gutteridge J. M. C. and Halliwell B. (1990) The measurement and mechanism of lipid peroxidation in biological systems. Trends Biochem. Sci. 15, 129-135.
24. Hall E. D. and Braughler J. M. (1989) Central nervous system trauma and stroke. II. Physiological and pharmacological evidence for involvement of oxygen radicals and lipid peroxidation. Free Radic. Biol. Med. 6, 303-313.
25. Halliwell B. and Chirico S. (1993) Lipid peroxidation: its mechanism, measurement, and significance. Am. J. Clin. Nutr. 57, 715S-725S.
26. Ince P. G., Shaw P. J., Candy J. M., Mantle D., Tandon L., Ehmann W. D., and Markesbery W. R. (1994) Iron, selenium and glutathione peroxidase activity are elevated in sporadic motor neuron disease. Neurosci. Lett. 182, 87-90.
27. Ince P. G., Shaw P. J., Slade J. Y., Jones C., and Hudgson P. (1996) Familial amyotrophic lateral sclerosis with a mutation in exon 4 of the Cu/Zn Superoxide dismutase gene: pathological and immunocytochemical changes. Acta Neuropathol. 92, 395-403.
28. Lai J. C. K. and Clark J. B. (1979) Preparation of synaptic and nonsynaptic mitochondria from mammalian brain. Methods Enzymol. 55, 51 -60.
29. 35S]glutathione binding sites in spinal cords from patients with sporadic amyotrophic lateral sclerosis. Neurosci. Lett. 163, 89-92.
30. Lazzarino G., Vagnozzi R., Tavazzi B., Pastore F. S., Di Pierro D., Siragusa P., Belli A., Giuffre R., and Giardina B. (1992) MDA, oxypurines, and nucleosides relate to reperfusion in short-term incomplete cerebral ischemia in the rat. Free Radic. Biol. Med. 13, 489-498.
31. Levine R. L., Garland D., Oliver C. N., Amici A., Climent I., Lenz A.-G., Ahn B.-W., Shaltiel S., and Stadtman E. R. (1990) Determination of carbonyl content in oxidatively modified proteins. Methods Enzymol. 186, 464-487.
32. Liu D., Yang R., Yan X., and McAdoo D. J. (1994) Hydroxyl radicals generated in vivo kill neurons in the rat spinal cord: electro-physiological, histological, and neurochemical results. J. Neurochem. 62, 37-44.
33. Lyons T. J., Liu H., Goto J. J., Nersissian A., Roe J. A., Graden J, A., Cafe C., Ellerby L. M., Bredesen D. E., Butler-Gralla E., and Selverstone-Valentine J. (1996) Mutations in copper-zinc Superoxide dismutase that cause amyotrophic lateral sclerosis alter the zinc binding site and the redox behavior of the protein. Proc. Natl. Acad. Sci. USA 93, 12240-12244.
34. Mecocci P., MacGarvey U., Kaufman A. E., Koontz D., Shoffner J. M., Wallace D. W., and Beal M. F. (1993) Oxidative damage to mitochondrial DNA shows marked age-dependent increases in human brain. Ann. Neurol 34, 609-616.
35. Michikawa M., Lim K. T., McLarnon J. G., and Kim S. U. (1994) Oxygen radical-induced neurotoxicity in spinal cord neuron cultures. J. Neurosci. Res. 37, 62-70.
36. Mulder D. W., Kurland L. T., Offord K. P., and Beard C. M. (1986) Familial adult motor neuron disease: amyotrophic lateral sclerosis. Neurology 36, 511-517.
37. Nakano R., Sato S., Inusuka T., Sakimura K., Mishina M., Takahashi H., Ikuta F., Nomna Y., Fujii J., Taniguchi N., and Tsuji S. (1994) A novel mutation in Cu/Zn Superoxide dismutase gene in Japanese familial amyotrophic lateral sclerosis. Biochem. Biophyx. Res. Commun. 200, 695-703.
38. Nimura T., Weinstein P. R., Massa S. M., Panter S., and Sharp F. R. (1996) Heme oxygenase-1 (HO-1) protein induction in rat brain following focal ischemia. Mol. Brain Res. 37, 201-208.
39. Paschen W., Uto A., Djuricic B., and Schmitt J. (1994) Hemeoxygenase expression after reversible ischemia of rat brain. Neurosci. Lett. 180, 5-8.
40. Phillis J. W. (1994) A "radical" view of cerebral ischemic injury. Prog. Neurobiol. 42, 441-448.
41. Przedborski S., Donaldson D. M., Murphy P. L., Hirsch O., Lange D., Naini A. B., McKenna-Yasek D., and Brown R. H. Jr. (1996a) Blood Superoxide dismutase, catalase and glutathione peroxidase activities in familial and sporadic amyotrophic lateral sclerosis. Neurodegeneration 5, 57-64.
42. Przedborski S., Donaldson D., Jakowec M., Kish S. J., Guttman M., Rosoklija G., and Hays A. P. (1996b) Brain Superoxide dismutase, catalase, and glutathione peroxidase activities in amyotrophic lateral sclerosis. Ann. Neurol. 39, 158-165.
43. Radunovic A. and Leigh P. N. (1996) Cu/Zn Superoxide dismutase gene mutations in amyotrophic lateral sclerosis: correlations between genotype and clinical features. J. Neurol. Neurosurg. Psychiatry 61, 565-572.
44. Ripps M. E., Huntley G. W., Hof P. R., Morrison J. H., and Gordon J. W. (1995) Transgenic mice expressing an altered murine Superoxide dismutase gene provide an animal model of amyotrophic lateral sclerosis. Proc. Natl. Acad. Sci. USA 92, 689-693.
45. Rosen D. R., Siddique T., Patterson D., Figlewicz D. A., Sapp P., Hentati A., Donaldson D., Goto J., O'Regan J. P., Deng H.-X., Rahmani Z., Krizus A., McKenna-Yasek D., Cayabyab A., Gaston S. M., Berger R., Tanzi R. E., Halperin J. J., Herzfeldt B., Van den Bergh R., Hung W.-Y., Bird T., Deng G., Mulder D. W., Smyth C., Laing N. G., Soriano E., Pericak-Vance M. A., Haines J., Rouleau G. A., Gusella J. S., Horvitz H. R., and Brown R. H. Jr. (1993) Mutations in Cu/Zn superoxide dismutase are associated with familial amyotrophic lateral sclerosis. Nature 362, 59-62.
46. Rouleau G. A., Clark A. W., Rooke K., Pramatarova A., Krizus A., Suchowersky O., Julien J.-P., and Figlewicz D. (1996) SOD1 mutation is associated with accumulation of neurofilaments in amyotrophic lateral sclerosis. Ann. Neurol. 39, 128-131.
47. Santos M. T., Valles J., Aznar J., and Vilches J. (1980) Determination of plasma malondialdehyde-like material and its clinical application in stroke patients. J. Clin. Pathol. 33, 973-976.
48. Sasaki S. and Iwata M. (1996) Impairment of fast axonal transport in the proximal axons of anterior horn neurons in amyotrophic lateral sclerosis. Neurology 47, 535-540.
49. Schipper H. M., Cisse S., and Stopa E.G. (1995) Expression of heme oxygenase-1 in the senescent and Alzheimer-diseased brain. Ann. Neurol. 37, 758-768.
50. Shaw P. J., Ince P. G., Falkous G., and Mantle D. (1995) Oxidative damage to protein in sporadic motor neuron disease spinal cord. Ann. Neurol. 38, 691-695.
51. Shibata N., Hirano A., Kobayashi M., Siddique T., Deng H.-X., Hung W.-Y., Kato T., and Asayama K. (1996) Intense Superoxide dismutase-1 immunoreactivity in intracytoplasmic hyaline inclusions of familial amyotrophic lateral sclerosis with posterior column involvement. J. Neuropathol. Exp. Neurol. 55, 481-490.
52. Siddique T., Figlewicz D. A., Pericak-Vance M. A., et al. (1991) Linkage of a gene causing familial amyotrophic lateral sclerosis to chromosome 21 and evidence of genetic locus heterogeneity. N. Engl. J. Med. 324, 1381-1384.
53. Siklos L., Engelhardt J., Harati Y., Smith R. G., Joo F., and Appel S. H. (1996) Ultrastructural evidence for altered calcium in motor nerve terminals in amyotrophic lateral sclerosis. Ann. Neurol. 39, 203-219.
54. Smith C. D., Carney J. M., Starke-Reed P. E., Oliver C. N., Stadtman E. R., Floyd R. A., and Markesbery W. R. (1991) Excess brain protein oxidation and enzyme of dysfunction in normal aging and Alzheimer disease. Proc. Natl. Acad. Sci. USA 88, 10540-10543.
55. Swerdlow R. H., Parks J. K., Miller S. W., Davis R. F., Pattee G., and Parker W. D. (1996) Evidence of genetic mitochondrial pathology in sporadic amyotrophic lateral sclerosis. Soc. Neurosci. Abstr. 22, 2413.
56. Tandan R. and Bradley W. G. (1985) Amyotrophic lateral sclerosis: Part 1. Clinical features, pathology, and ethical issues in management. Ann. Neurol. 184, 271-280.
57. Troncoso J. C., Costello A. C., Kim J. H., and Johnson G. V. W. (1995) Metal-catalyzed oxidation of bovine neurofilaments in vitro. Free Radic. Biol Med. 18, 891-899.
58. Wiedau-Pazos M., Goto J. J., Rabizadeh S., Gralla E. B., Roe J. A., Lee M. K., Valentine J. S., and Bredesen D. E. (1996) Altered reactivity of Superoxide dismutase in familial amyotrophic lateral sclerosis. Science 271, 515-518.
59. Wong P. C., Pardo C. A., Borchelt D. R., Lee M. K., Copeland N. G., Jenkins N. A., Sisodia S. S., Cleveland D. W., and Price D. L. (1995) An adverse property of a familial ALS-linked SOD1 mutation causes motor neuron disease characterized by vacuolar degeneration of mitochondria. Neuron 14, 1105-1116.
60. m for hydrogen peroxide. Proc. Natl. Acad. Sci. USA 93, 5709-5714.